Dr. Kavadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1350 First Colony Blvd
Sugar Land, TX 77479Phone+1 281-277-5200Fax+1 281-276-3492
Education & Training
- University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1989 - 1993
- Baylor College of MedicineInternship, Transitional Year, 1988 - 1989
- Harvard Medical SchoolClass of 1988
Certifications & Licensure
- CA State Medical License 1993 - 2025
- TX State Medical License 1989 - 2024
- MD State Medical License 1994 - 1996
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
Clinical Trials
- Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Start of enrollment: 2008 Feb 01
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 1311 citationsStandard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage I...Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki, Gregory A. Masters, George R. Blumenschein
The Lancet. Oncology. 2015-02-01 - 465 citationsImpact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomize...Stephen G. Chun, Chen Hu, Hak Choy, R.U. Komaki, Robert Timmerman
Journal of Clinical Oncology. 2017-01-01 - 263 citationsLong-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.Jeffrey D. Bradley, Chen Hu, Ritsuko Komaki, Gregory A. Masters, George R. Blumenschein
Journal of Clinical Oncology. 2020-03-01
Press Mentions
- Amar Rewari, MD, MBA, FASTRO, Appointed Health Policy Council Vice-ChairAugust 30th, 2024
- Launch of Covid-19 Vaccine in India Has ‘Rescued the World’ from Pandemic, Says Leading American Scientist India NewsMarch 7th, 2021
- Leaders in Radiation Oncology Awarded ASTRO Fellow DesignationAugust 8th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: